000132851 001__ 132851
000132851 005__ 20240229105035.0
000132851 0247_ $$2doi$$a10.1177/1062860617707262
000132851 0247_ $$2pmid$$apmid:28460533
000132851 0247_ $$2ISSN$$a1062-8606
000132851 0247_ $$2ISSN$$a1555-824X
000132851 0247_ $$2altmetric$$aaltmetric:20938118
000132851 037__ $$aDKFZ-2018-00494
000132851 041__ $$aeng
000132851 082__ $$a610
000132851 1001_ $$aPowell, Rhea E$$b0
000132851 245__ $$aA Multidisciplinary Approach to Impact Acute Care Utilization in Sickle Cell Disease.
000132851 260__ $$aThousand Oaks, Calif. [u.a.]$$bSage Publ.$$c2018
000132851 3367_ $$2DRIVER$$aarticle
000132851 3367_ $$2DataCite$$aOutput Types/Journal article
000132851 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1525867704_22379
000132851 3367_ $$2BibTeX$$aARTICLE
000132851 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000132851 3367_ $$00$$2EndNote$$aJournal Article
000132851 520__ $$aSickle cell disease (SCD), an inherited red blood cell disorder, is characterized by anemia, end-organ damage, unpredictable episodes of pain, and early mortality. Emergency department (ED) visits and hospitalizations are frequent, leading to increased burden on patients and increased health care costs. This study assessed the effects of a multidisciplinary care team intervention on acute care utilization among adults with SCD. The multidisciplinary care team intervention included monthly team meetings and development of individualized care plans. Individualized care plans included targeted pain management plans for management of uncomplicated pain crisis. Following implementation of the multidisciplinary care team intervention, a significant decrease in ED utilization was identified among those individuals with a history of high ED utilization. Findings highlight the potential strength of multidisciplinary interventions and suggest that targeting interventions toward high-utilizing subpopulations may offer the greatest impact.
000132851 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000132851 588__ $$aDataset connected to CrossRef, PubMed,
000132851 7001_ $$aLovett, Paris B$$b1
000132851 7001_ $$aCrawford, Albert$$b2
000132851 7001_ $$aMcAna, John$$b3
000132851 7001_ $$aAxelrod, David$$b4
000132851 7001_ $$aWard, Lawrence$$b5
000132851 7001_ $$0P:(DE-He78)3772dc9cbbc020fbc52b5f63f1dc1e96$$aPulte, Dianne$$b6$$eLast author$$udkfz
000132851 773__ $$0PERI:(DE-600)2181248-2$$a10.1177/1062860617707262$$gVol. 33, no. 2, p. 127 - 131$$n2$$p127 - 131$$tAmerican journal of medical quality$$v33$$x1555-824X$$y2018
000132851 909CO $$ooai:inrepo02.dkfz.de:132851$$pVDB
000132851 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3772dc9cbbc020fbc52b5f63f1dc1e96$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000132851 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000132851 9141_ $$y2018
000132851 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000132851 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000132851 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000132851 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bAM J MED QUAL : 2015
000132851 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000132851 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000132851 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000132851 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000132851 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000132851 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000132851 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000132851 980__ $$ajournal
000132851 980__ $$aVDB
000132851 980__ $$aI:(DE-He78)C070-20160331
000132851 980__ $$aUNRESTRICTED